Sensei Biotherapeutics, Inc.
SNSE
$21.08
$0.080.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.09M | -24.14M | -26.82M | -29.03M | -30.16M |
| Total Depreciation and Amortization | 139.00K | 436.00K | 734.00K | 1.03M | 1.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.09M | 2.95M | 3.32M | 3.78M | 4.65M |
| Change in Net Operating Assets | -1.59M | -1.63M | -1.49M | 79.00K | -489.00K |
| Cash from Operations | -20.45M | -22.38M | -24.27M | -24.15M | -24.67M |
| Capital Expenditure | -16.00K | -16.00K | -16.00K | -109.00K | -146.00K |
| Sale of Property, Plant, and Equipment | 250.00K | 250.00K | 250.00K | 40.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.54M | 14.31M | 25.48M | 23.93M | 22.59M |
| Cash from Investing | 19.77M | 14.54M | 25.71M | 23.86M | 22.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -790.00K | -884.00K | -936.00K | -823.00K | -811.00K |
| Issuance of Common Stock | 7.00K | 18.00K | 18.00K | 34.00K | 34.00K |
| Repurchase of Common Stock | -4.00K | -4.00K | -3.00K | -3.00K | -10.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 142.00K | 142.00K | 141.00K | -- | -- |
| Cash from Financing | -645.00K | -728.00K | -780.00K | -792.00K | -787.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.33M | -8.57M | 666.00K | -1.08M | -3.02M |